India
Sign In
Search
Trending stocks
07:47 PM 09-05-2026
Divi'S Laboratories
Divi
Industry: Pharmaceuticals
Ticker
Exchange
ISIN
Name
$DIVISLAB
BSE
INE361B01024
Code: 532488
$DIVISLAB
NSE
INE361B01024
Recent news
Fertilizers & Chemicals Travancore reports 2,795% EBITDA growth in 2020 and 9.6 pp EBITDA Margin growth from 0.49% to 10.1%
Ginni Filaments EBITDA jumped on 15.6% while Revenue decreased slightly on 1.3%
Ajel Net Income dropped on 148% while EBITDA Margin increased on 3.9 pp from -11.7% to -7.8%
Gulf Oil Corporation Net Debt / EBITDA jumped on 70.0x from 5.2x to 75.2x in 2020 while Revenue decreased on 6.3%
Royal Orchid Hotels Net Income dropped on 58.9% and Revenue increased slightly on 0.59%
Media Matrix Worldwide Net Income dropped on 95.2% and Revenue dropped on 31.1%
Sindhu Trade Links reports 250% Net Income growth in 2020 while 58.9% Revenue decline
Jay Shree Tea & Industries reports 318% EBITDA decline in 2020 and 5.2% Revenue decline
Hexaware Technologies revenue jumped on 20.1% and EBITDA Margin showed almost no change
Fertilizers & Chemicals Travancore Net Debt / EBITDA jumped on 221.9x from 13.3x to 235.2x in 2019 and Revenue increased slightly on 1.3%
Twit about DIVISLAB stock
Share your investment idea or question on
Divi'S Laboratories
stock:
$DIVISLAB
#Bullish
#Bearish
POST
Latest twits on Divi'S Laboratories (DIVISLAB)
No twits yet. Be the first to post!
Have a question about DIVISLAB? Ask and other investors will be eager to help you.
Have an idea about DIVISLAB? Share it with other investors.
Divi'S Laboratories news
04-06-2016 Divi'S Laboratories is an attractive stock for a growth investor
28-05-2016 Divi'S Laboratories Net Income surged on 30.6% and EBITDA Margin showed almost no change
30-05-2015 Looking for growth stocks? Pay attention to Divi'S Laboratories
23-05-2015 Divi'S Laboratories CAPEX surged on 24.7% in 2015 and Revenue surged on 23.3%
31-05-2014 Divi'S Laboratories is an attractive growth stock
Divi'S Laboratories stock price chart
Divi'S Laboratories financials
mln. INR
FY2010
FY2011
FY2012
Revenue
37,107
13,071
18,584
EBITDA
4,166
4,983
6,915
Net income
3,403
4,293
5,333
CAPEX
601.7
1,627
2,892
Debt
328.5
230.5
527.6
Cash
133.9
144.8
173.2
Divi'S Laboratories news
04-06-2016 Divi'S Laboratories is an attractive stock for a growth investor
28-05-2016 Divi'S Laboratories Net Income surged on 30.6% and EBITDA Margin showed almost no change
30-05-2015 Looking for growth stocks? Pay attention to Divi'S Laboratories
23-05-2015 Divi'S Laboratories CAPEX surged on 24.7% in 2015 and Revenue surged on 23.3%
31-05-2014 Divi'S Laboratories is an attractive growth stock
About Divi'S Laboratories
Divi
Forgot password?
Sign Up
Sign In
